TKT and prostate carcinoma: In a clinical study of rAd-HSV-TK, a recombinant replication-deficient adenovirus vector carrying the HSV-TK (thymidine kinase) gene, intraprostatic injections of rAd-HSV-TK in patients with prostate cancer induced tumor infiltrating B and T cells11.